News Focus
News Focus
icon url

sharkey1

10/27/24 2:00 PM

#412877 RE: bchoe #412876

THX, bchoe, very good report.
icon url

rocioyogi

10/27/24 2:28 PM

#412878 RE: bchoe #412876

Facility Expansion: A Pillar for Sustained Growth
ELTP’s expanded facility is not merely designed to meet immediate demand for Generic Vyvanse. It is structured to support a broader pipeline of products, including upcoming launches like Generic Percocet and Generic Norco. This scalability ensures ELTP can efficiently manage growth and maintain market competitiveness in both the ADHD and pain management segments for years to come.
icon url

jammy32

10/27/24 4:25 PM

#412886 RE: bchoe #412876

Is this from Goldman, JP Morgan, Citi, or some other credible source
icon url

Trend-Setter

10/27/24 4:39 PM

#412888 RE: bchoe #412876

Excellent post. Thank you!
That report has a sophisticated approach. Impressive! I appreciate you. Keep it up!
icon url

HGiLS

10/28/24 10:36 AM

#412913 RE: bchoe #412876

Nice pinned post - deserves bunch of Thumbs up ::)
icon url

WALLnut

10/28/24 2:54 PM

#412930 RE: bchoe #412876

To all: Read this post and mark it. Awesome display of information. Thanks again bchoe for sharing.



ELTP